Revolution Medicines Announces Pricing of Initial Public Offering

NASDAQ Market News

NEXT STORY
Tero Närvänen is appointed Orion’s new Vice President Quality Management as of 1 May 2020
PREV STORY
Guardant Health to Participate in Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results

-On track to begin CTX001 clinical study in hemoglobinopathies in 2018--On track to file ...

author_avatar
NASDAQ Market News

Immune Design Reports Third Quarter 2016 Financial Results and Provides Corporate Update

SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Immune Design ...

author_avatar
NASDAQ Market News

Mateon Announces Issuance of US Patent for Cathepsin Inhibition

SOUTH SAN FRANCISCO, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (Nasdaq:MATN), ...

author_avatar
NASDAQ Market News